ESPINOZA OCTAVIO (Chief Financial Officer) sold 6.4% of their position (1.80K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $339.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/16/2025ACC: 0002001011-25-000125
Officer· Chief Financial Officer
Since Mar 2026
-1.80K
Net shares
Net seller
$339.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.80K
Price / share
$188.31
Trade value
$339.71K
% of position
6.4%
12/12/2025
27.99K→26.19K
Total
Net shares
−1.80K
Net value
-$339.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | S · Sale | −1.80K | $188.31 | $339.71K | 6.4% | 27.99K | 26.19K |
| Total | −1.80K | -$339.71K | ||||||
Derivative Transactions0
No derivative transactions reported